18d
Pharmaceutical Technology on MSNKenox and Lactiga partner on sIgA therapies for immunodeficiencyKenox Pharmaceuticals and Lactiga US have announced a strategic partnership to progress the development of new mucosal-targeted secretory IgA (sIgA) therapies, focusing on enhancing immunity for ...
Scientists at UMC Utrecht have developed a new technology to efficiently isolate a specific subset of gut bacteria from fecal samples that are recognized by IgA antibodies. These "IgA-coated" bacteria ...
[16] Breast milk contains high concentration of secretory antibodies, mainly IgA, with a broad range of specificities reflecting both maternal immunologic memory and antigenic stimulation of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results